| Primary |
| Hypertension |
45.2% |
| Angina Pectoris |
19.4% |
| Cardiac Failure |
9.7% |
| Dyslipidaemia |
6.5% |
| Gastritis Prophylaxis |
6.5% |
| Transient Ischaemic Attack |
6.5% |
| Coronary Artery Disease |
3.2% |
| Microvascular Coronary Artery Disease |
3.2% |
|
| Hypokalaemia |
23.5% |
| Presyncope |
11.8% |
| Vision Blurred |
11.8% |
| Anaphylactic Shock |
5.9% |
| Diarrhoea |
5.9% |
| Polyneuropathy |
5.9% |
| Renal Failure |
5.9% |
| Rhabdomyolysis |
5.9% |
| Sinus Bradycardia |
5.9% |
| Syncope |
5.9% |
| Vertigo Positional |
5.9% |
| Vomiting |
5.9% |
|
| Secondary |
| Angina Pectoris |
33.3% |
| Hypertension |
33.3% |
| Coronary Artery Disease |
16.7% |
| Gastritis Prophylaxis |
16.7% |
|
| Hypokalaemia |
33.3% |
| Rhabdomyolysis |
33.3% |
| Syncope |
33.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.0% |
| Hypertension |
15.1% |
| Drug Use For Unknown Indication |
12.1% |
| Myocardial Ischaemia |
5.0% |
| Angina Pectoris |
4.1% |
| Diabetes Mellitus |
3.2% |
| Prophylaxis |
3.0% |
| Depression |
2.5% |
| Hypercholesterolaemia |
2.5% |
| Atrial Fibrillation |
2.1% |
| Ill-defined Disorder |
2.1% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Pain |
1.8% |
| Cardiac Failure Chronic |
1.4% |
| Hypothyroidism |
1.4% |
| Non-small Cell Lung Cancer Stage Iv |
1.4% |
| Oesophageal Carcinoma |
1.4% |
| Osteoporosis |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Type 1 Diabetes Mellitus |
1.4% |
|
| Hypotension |
9.7% |
| Renal Failure |
9.7% |
| Vomiting |
9.7% |
| International Normalised Ratio Increased |
8.3% |
| Myocardial Infarction |
8.3% |
| Pruritus |
5.6% |
| Thrombocytopenia |
5.6% |
| Visual Impairment |
5.6% |
| Hypoglycaemia |
4.2% |
| Palpitations |
4.2% |
| Syncope |
4.2% |
| Cardiac Failure |
2.8% |
| Dementia |
2.8% |
| Eczema |
2.8% |
| Gastrointestinal Haemorrhage |
2.8% |
| Hyperkalaemia |
2.8% |
| Hyperpyrexia |
2.8% |
| Hypokalaemia |
2.8% |
| Muscle Spasms |
2.8% |
| Oedema |
2.8% |
|
